Topic: United States
Top Indian generic drugmaker Ranbaxy Laboratories on Friday reported a 25 percent drop in its second-quarter net profit, buffeted by US regulatory problems, but it still beat market forecasts.Net profit for the generic and branded pharma giant, which is controlled by Japan's ...
PHILADELPHIA (Reuters) - Relatives of a man whose chemist wife is accused of poisoning him with thallium have filed a wrongful death lawsuit against the pharmaceutical company where she worked and the hospital where he died.Xiaoye Wang, 39, a computer engineer also ...
LONDON (Reuters) - AstraZeneca Plc has no plans to run a clinical trial to confirm the reasons behind a discrepancy between the performance of its newly approved heart drug Brilinta in North America and other parts of the world.Some analysts have speculated ...
ZURICH (Reuters) - Novartis expects volume growth at its pharma unit to more than offset the impact of generic competition, the Swiss drugmaker said after posting a 27 percent rise in second-quarter sales.The Basel-based group's core earnings per share jumped 23 percent ...
NEW YORK (Reuters) - GlaxoSmithKline Plc will pay nearly $41 million to 37 U.S. states and the District of Columbia to settle allegations related to faulty drug manufacturing processes at a former factory in Puerto Rico.Under terms of the pact announced Thursday ...
WASHINGTON (Reuters) - The Supreme Court ruled on Thursday that generic drug companies cannot be sued under state law over allegations that they failed to provide adequate label warnings about potential side effects.The justices handed a victory to Israel's Teva Pharmaceutical Industries ...
NEW YORK (Reuters) - Billionaire investor Carl Icahn is taking aim at Forest Laboratories Inc's longtime chief executive officer as he seeks to shake up the U.S. drugmaker's board.In a U.S. securities filing, Icahn criticized Forest's board for spending to defend CEO ...
NEW YORK (Reuters) - Danish drugmaker Novo Nordisk will pay $25 million to settle a lawsuit over the alleged improper marketing of its anti-clotting medicine NovoSeven.The company said on Friday that it will pay the U.S. government $25 million to resolve a ...
WASHINGTON (Reuters) - Pfizer Inc has agreed to suspend U.S. sales of a popular poultry drug after a study found the drug increased levels of a carcinogen in chickens, U.S. health officials said on Wednesday.A study from the Food and Drug Administration ...
LONDON (Reuters) - Prompted by the soaring cost of developing and marketing their medicines, drug companies are embracing the Internet in a bid to drive down costs.The hope is that digital tools will not only make them more efficient, but also smarter ...
Photo Gallery
-
South Korea Koreas Clash
South Korean Foreign Minister Kim Sung-hwan, right, shakes hands with U.S ...AP News - -
Hawks Kings Basketball
Sacramento Kings forward Carl Landry, center, goes to the basket against Atlanta ...AP News - -
Blue Jackets Coyotes Hockey
Columbus Blue Jackets' R.J. Umberger (18) scores a goal against Phoenix ...AP News -
